Ideaya aims to raise $263M; Immuneel extends Series A with $12M

Plus, news about XyloCor, Pfizer, Evotech, Skyhawk Therapeutics, HepaRegeniX and Vyome:

Ideaya Biosciences’ $263M public offering: The South San Francisco, CA-based biotech

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Beyond the gut: Crohn’s disease’s oral clues for timely diagnosis

The oral manifestations of CD.

October 12, 2023

Republicans consider a new attack on Biden ‘march-in’ plan for lower drug prices

WASHINGTON — Republicans in Congress might try to use a technical maneuver to block the Biden administration from using so-called march-in rights to seize pharmaceutical

March 6, 2024

Consumption of UPFs increases the risk of cancer and cardiometabolic multimorbidity

The association between UPF consumption and cancer, cardiovascular disease, and type 2 diabetes.

November 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.